Quince Therapeutics, Inc. (Nasdaq: QNCX) is a late-stage biotechnology company dedicated to unlocking the power of a patient's own biology for the treatment of rare diseases. For more information on ...

In the whirlpool of broken narratives, post-truth dissonances, and chaos, every inch of newspaper space taken up by absurdity is wasted space.

Discover the unique tradition of the Konda Reddi tribe in Andhra Pradesh, celebrating summer with bamboo shoots and fish.

World leaders, tech giants, and experts gather at a Paris summit to debate AI’s future, but concerns grow over regulatory ...

A recent report from Stifel showed that 30% of licensing deals from big pharma companies now involve a Chinese biotech.

Leerink Partners analyst Faisal Khurshid has reiterated their bullish stance on GERN stock, giving a Buy rating yesterday.Invest with ...

Jinxin Technology Holding Company (the "Company") , an innovative provider of digital-content products and services in China, today announced an in-depth strategic partnership with Tencent Cloud and ...

Teenager Tali Pipe is passionate about giving Indigenous young people opportunities so they can reach their potential.

SOUTH SAN FRANCISCO, Calif. - Quince Therapeutics, Inc. (NASDAQ: QNCX), a biotech firm focusing on rare diseases with a current market capitalization of $67.76 million, has received a Notice of ...

This team has shown from start to finish how microbes can transform waste that’s available on many dairy plants right now, says Stephanie Lansing, a bioenergy and biotechnology expert ... and a ...